Otsuka Holdings Co., Ltd. OTSKF
73.16 USD 0.00 (+0.00%)
At closeNov 12, 2026, 4:00 PM EST
72.00 Day range 72.00
54.26 52-week range 79.00
- YTD
- +34.82%
- 1 year
- +26.68%
News
seekingalpha.com Aristotle International Equity ADR WM Q1 2026 Contributors And Detractors For the first quarter of 2026, Aristotle Capital's International Equity ADR WM Composite posted a total return of -3.39% gross of fees. MonotaRO, the Japanese business-to-business e-commerce…
seekingalpha.com Otsuka Holdings Co., Ltd. (OTSKY) M&A Call Prepared Remarks Transcript Otsuka Holdings Co., Ltd. (OTSKY) M&A Call Prepared Remarks Transcript
seekingalpha.com Otsuka Holdings Co., Ltd. (OTSKY) Q4 2025 Earnings Call Prepared Remarks Transcript Otsuka Holdings Co., Ltd. (OTSKY) Q4 2025 Earnings Call Prepared Remarks Transcript
benzinga.com Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment William Blair upgrades Neumora after strong Alzheimer's agitation data, sees upside from NMRA-511 and obesity pipeline potential.
defenseworld.net Otsuka (OTCMKTS:OTSKF) Trading Up 3% – Should You Buy? Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKF - Get Free Report) shares shot up 3% during mid-day trading on Wednesday. The company traded as high as $61.42 and last traded at $61.42. 200 shares traded…
benzinga.com Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle CMS selects 15 high-cost prescription drugs for Medicare drug price negotiation program, expanding to include Part B drugs.
reuters.com US FDA approves Otsuka's kidney disease drug The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially life-threatening kidney disease, the health regulator's website showed on Tuesday.
seekingalpha.com Otsuka Corporation (OSUKF) Q1 FY2025 Earnings Call Transcript Otsuka Corporation (OTCPK:OSUKF) Q1 FY2025 Earnings Conference Call August 1, 2025 2:30 AM ET Company Participants Yuji Otsuka - CEO, President, Chairman & MM Division Chief Yuji Otsuka I am Otsuka…